The Liver Meeting 2023: Innovating for people living with rare liver diseases
Jennifer Schranz (Ipsen’s Global Head of Rare Diseases) attended The Liver Meeting from November 10-14, sharing key insights from her time onsite and explaining why scientific congresses are vital in helping advance innovation for patients.
With an exciting number of sessions and abstracts focused on cholestatic liver diseases, Jennifer tells us why rare cholestatic liver diseases are in focus.
The Liver Meeting is an annual congress run by the American Association for the Study of Liver Diseases (AASLD) in which experts from around the world gather to share and discuss the latest research, insights, and advancements in liver diseases. This year, the five-day meeting was held in Boston, Massachusetts.
A Journey of Strength and Hope, Joris and Maria’s story
Céline and Suzanne: Navigating Alagille Syndrome
Living with Rare Liver Diseases: Unique challenges, Shared Experiences
Scientific Journey from Coal to Diamond: Myths and Misperceptions in Rare Disease Innovation
Breaking Barriers to Rare Disease Innovation: Reflections from the World EPA Congress
Rare Disease Day 2025: Imagining More for the Rare Disease Community
Imagining More for Rare Diseases: Reflections on the Path Ahead
Together for ALGS Awareness Day
Advocating for babies with Biliary Atresia
Looking after a loved one with Progressive Familial Intrahepatic Cholestasis: Francesca’s Story